- References (1)
- Inventor Info
|Parental Line||Msh3-/- SVG-A Cell Line|
|Relevance||This cell line was derived from the SVG-A Msh3-/- (knock-out generated by CRISPR)) cell line whereby the DNA mismatch repair protein Msh3 expression has been reinstated.|
|Research Area||DNA Damage and Repair, Neurobiology, Virology|
|Recommended Growing Conditions||DMEM supplemented with 10% FBS|
CRISPR edited cells.
Cancer Research Technology Limited (trading research tools as Ximbio) has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here.
This license from ERS Genomics Ltd allows Ximbio to develop and commercialise CRISPR-Cas9 modified cell lines for research use only. Ximbio can provide these modified CRISPR-Cas9 cell lines to companies under a label-use only license.
There are 1 reference entries for this reagent.View All References